Sagimet Biosciences stock rises after pricing $115M securities offering
Sagimet Biosciences stock rises after pricing $115M securities offering tradingview.com
Covered in this story
What has happened since
- Sagimet Biosciences is down 8.3% since this was published, 5 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Sagimet Biosciences
- Citizens JMP: $9.37 → $27 by Oct 2027 · Market Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $SGMT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Sagimet Biosciences →Summary aggregated from tradingview.com's public RSS feed. The full reporting belongs to tradingview.com — please read it on their site.